Bliss Gvs Pharma Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1984.

1984 Mumbai, Maharashtra, India Active

Last Updated: January 09, 2026

About Bliss Gvs Pharma Limited

Bliss Gvs Pharma Limited, a active public limited company, was established on 11 December 1984 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24230MH1984PLC034771. Registered under ROC Roc Mumbai. it is listed on BSE: 506197 and NSE: BLISSGVS. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹10.58 Cr.

Formerly known as Bliss Gvs Phrma Limited (Cn), Bliss Chemicals And Pharmaceuticals India Limited. It upholds a compliant status. In 2025, it reported revenue of ₹703.42 Cr and a net worth of ₹1,058.63 Cr. Employing 926 professional, Its leadership includes Vibha Gagan Sharma (Whole-Time Director), Santosh Laxman Parab (Director), Nandkumar Kashinath Chodankar (Director). Past directors included Vipul Babulal Thakkar, Narsimha Shibroor Kamath, Vibha Gagan Sharma. It holds ₹261.00 Cr open charges and ₹301.25 Cr settled loans. Its latest AGM occurred on 31 July 2025, with the balance sheet filed on 31 March 2025. It is based at 102, Hyde Park, Sakivihar Road, Andheri (East)., Mumbai, Maharashtra, 400072.

Company Details

CIN/LLPIN
L24230MH1984PLC034771
Registration Number
034771
Incorporation Date
11 December 1984
Authorized Capital
₹15.00 Cr
Paid-Up Capital
₹10.58 Cr
ROC Code
Roc Mumbai
Listing Status
Listed (BSE: 506197, NSE: BLISSGVS)
Company Status
Active

Key Metrics

Authorised Capital ₹ 15.00 Cr as on 09-01-2026
Paid Up Capital ₹ 10.58 Cr as on 09-01-2026
Company Age 41 Year, 6 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 261.00 Cr as on 09-01-2026
Satisfied Charges ₹ 301.25 Cr as on 09-01-2026
Revenue Growth **** 10.09% (FY 2025)
Profit Growth **** 36.18% (FY 2025)
Ebitda **** 19.25% (FY 2025)
Net Worth 7.1% (FY 2025)
Total Assets -8.43% (FY 2025)

Comprehensive Company Insights

Explore comprehensive insights into Bliss Gvs Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Bliss Gvs Pharma Limited?

Current Directors

Name	Designation	Appointment Date	Status
Vibha Gagan Sharma	Whole-Time Director	29 Jul 2008	Current
Santosh Laxman Parab	Director	24 May 2016	Current
Nandkumar Kashinath Chodankar	Director	22 Jun 2024	Current
Shilpa Bhatia	Director	11 Feb 2020	Current
Shruti Vishal Rao	Whole-Time Director	27 Jul 2006	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Cfo(Kmp)	14 Aug 2020	Past
Pramod Abcsdd	Managing Director	11 May 2021	Past
Pramod Abcsdd	Director	27 Jan 2010	Past
Pramod Abcsdd	Additional Director	14 Sep 2016	Past
Pramod Abcsdd	Additional Director	24 Jul 2024	Past
Pramod Abcsdd	Additional Director	11 May 2021	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Bliss Gvs Pharma.

Bliss Gvs Pharma Limited, for the financial year ended 2025, experienced significant growth in revenue, with a 10.09% increase. The company also saw a substantial improvement in profitability, with a 36.18% increase in profit. The company's net worth moved up by a moderate rise of 7.1%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

10.09%

*******

Revenue from Operations

*******

10.2%

*******

Total Assets

*******

-8.43%

*******

Profit or Loss

*******

36.18%

*******

Net Worth

*******

7.1%

*******

EBITDA

*******

19.25%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Bliss Gvs Pharma?

In 2023, Bliss Gvs Pharma had a promoter holding of 35.04% and a public holding of 64.96%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹2,610,000,000.00

Satisfied Charges

₹3,012,483,000.00

Charges Breakdown by Lending Institutions

Others : 260.00 Cr
Hdfc Bank Limited : 1.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
16 Dec 2023	Others	₹35.00 Cr	Open
02 Sep 2023	Others	₹75.00 Cr	Open
17 Sep 2021	Others	₹65.00 Cr	Open
21 Nov 2020	Hdfc Bank Limited	₹1.00 Cr	Open
07 Oct 2006	Others	₹85.00 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Bliss Gvs Pharma?

Bliss Gvs Pharma has a workforce of 926 employees as of Mar 31, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Bliss Gvs Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bliss Gvs Pharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Bliss Gvs Pharma

Recent Activity within the Organization

Director Appointment

Narsimha Shibroor Kamath was appointed as a Ceo was appointed as a Ceo on 10 Oct 2025 & has been associated with this company since 8 months 12 days . was recorded as a recent event.
10 Oct 2025
Annual General Meeting

Bliss Gvs Pharma Limited last Annual general meeting of members was held on 31 Jul 2025 as per latest MCA records. was recorded as a recent event.
31 Jul 2025
Balance Sheet

Progress on Bliss Gvs Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
31 Mar 2025
Charges

Progress on A charge with Others of Rs. 75.00 Cr registered on 02 Sep 2023 with Charge ID 100791236 was modified on 30 Jan 2025. was documented.
30 Jan 2025
Director Appointment

The activity Nandkumar Kashinath Chodankar was appointed as a Director was appointed as a Director on 22 Jun 2024 & has been associated with this company since 2 years . was completed.
22 Jun 2024
Charges

A charge with Others of Rs. 35.00 Cr registered on 16 Dec 2023 with Charge ID 100843177 was modified on 22 Dec 2023. was recorded as a recent event.
22 Dec 2023

Explore recent activity and updates - View Recent Activity